The Administration Core includes Consortium Administration and Senior Leadership. Consortium Administration provides high quality, efficient and effective support to cancer center leaders, programs and members. Administration plays a major role in enabling the Consortium's scientific leaders to define the center's vision and strategic goals, implement initiatives, monitor progress in achieving objectives and secure needed resources to develop the requisite infrastructure to carry out the center's mission. Senior Leaders work together to establish a vision and implement strategies of high importance to the cancer center's development. In addition to the Center Director, Dr. Corey, senior leadership includes: two Deputy Directors, including one who oversees Clinical Research; three scientific Associate Directors (AD) for Basic Sciences, Population Sciences, and Childhood Cancers; four ADs for special areas that are high strategic priorities of the center (Solid Tumor Translational Research, Global Oncology, Minority Health and Health Disparities, Inter-Institutional Initiatives), and an AD for Administration. Together, Administration and Senior Leaders provide the necessary leadership and structure to ensure that the center is well positioned to achieve its overarching goals to improve diagnosis, treatment and prevention of cancer.
The Specific Aims of this core are to provide: 1. Efficient and cost-effective administrative coordination for the cancer center including support for CCSG grant administration, budget management, communication and coordination across the partners, and other administrative functions to support and optimize the Consortium's research productivity. 2. Efficient oversight and management of CCSG Shared Resources to assure provision of services of the highest quality. 3. Expert leadership for clinical, basic and population-based cancer research; and other areas that are high strategic priorities of the center. 4. Executive leadership and oversight of planning and execution of the cancer center vision; fostering interdisciplinary translational and inter-institutional research of the center; engaging members in the center; fostering team science and career development; and addressing the health needs of the catchment area through research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-44
Application #
9617702
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
44
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Miller, Chris P; Tsuchida, Connor; Zheng, Ying et al. (2018) A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis. Neoplasia 20:610-620
Baker, K Scott; Syrjala, Karen L (2018) Long-term complications in adolescent and young adult leukemia survivors. Hematology Am Soc Hematol Educ Program 2018:146-153
Gavvovidis, Ioannis; Leisegang, Matthias; Willimsky, Gerald et al. (2018) Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Clin Cancer Res 24:3644-3655
Paulson, K G; Voillet, V; McAfee, M S et al. (2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A et al. (2018) Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biol Blood Marrow Transplant 24:2211-2215
Witzky, Anne; Hummels, Katherine R; Tollerson 2nd, Rodney et al. (2018) EF-P Posttranslational Modification Has Variable Impact on Polyproline Translation in Bacillus subtilis. MBio 9:
Rosenthal, Elisabeth A; Shirts, Brian H; Amendola, Laura M et al. (2018) Rare loss of function variants in candidate genes and risk of colorectal cancer. Hum Genet 137:795-806
Verboon, Jeffrey M; Decker, Jacob R; Nakamura, Mitsutoshi et al. (2018) Correction: Wash exhibits context-dependent phenotypes and, along with the WASH regulatory complex, regulates Drosophila oogenesis (doi:10.1242/211573). J Cell Sci 131:

Showing the most recent 10 out of 1267 publications